<DOC>
	<DOCNO>NCT02830204</DOCNO>
	<brief_summary>The purpose study establish safety feasibility Edwards SAPIEN 3 valve subject mitral annular calcification ( MAC ) associate mitral stenosis ( MS ) and/or mitral regurgitation high-risk mitral valve surgery deem inoperable due extent calcification .</brief_summary>
	<brief_title>Surgical Implantation TRAnscatheter vaLve Native Mitral Annular Calcification ( SITRAL ) Study</brief_title>
	<detailed_description>Technical Success : Alive , - Successful access , delivery retrieval device delivery system , - Deployment correct positioning ( include repositioning/recapture need ) single intend device , - No need additional unplanned emergency surgery re-intervention related device access procedure Device Success : Alive stroke free , - Original intend device place , - No additional surgical interventional procedure related access device since completion original procedure ( i.e. , exit cath lab/Operating Room ( OR ) ) , - Intended performance device : - Structural performance : No migration , embolization , detachment , fracture , hemolysis , thrombosis ( include reduce leaflet motion ) endocarditis , etc , - Hemodynamic performance : Maintenance relief stenosis insufficiency without produce opposite ( Stenosis = Mitral Valve Area ( MVA ) &lt; 1.5cm2 Mitral Valve ( MV ) gradient &gt; 5mmHg , Insufficiency = Mitral Regurgitation ( MR ) &gt; 1+ ) , - Absence para-device complication ( e.g. , Paravalvular Leak ( PVL ) &gt; mild , need Permanent Pacemaker ( PPM ) , erosion , Annular rupture Aortic Valve ( AV ) Groove disruption , Left Ventricular Outflow Tract ( LVOT ) gradient increase &gt; 10mmHg ) Procedural Success : Device success , - No device procedure relate Serious Adverse Events ( SAEs ) ( Life threaten bleed ; major vascular cardiac structural complication require unplanned reintervention surgery ; stage 2 3 Acute Kidney Injury ( include new dialysis ) ; Myocardial Infarction ( MI ) need percutaneous coronary intervention ( PCI ) /coronary artery bypass graft ( CABG ) ; severe heart failure ( HF ) hypotension require intravenous ( IV ) inotrope , ultrafiltration mechanical circulatory support ; prolong intubation ( &gt; 48 hour ) 6.2 Secondary objective ( ) Device Success ( 6 month 1 year ) - Subject success 1 year Device Success : Alive stroke free , - Original intend device place , - No additional surgical interventional procedure related access device since completion original procedure ( i.e. , exit cath lab/Operating Room ( OR ) ) , - Intended performance device : - Structural performance : No migration , embolization , detachment , fracture , hemolysis , thrombosis ( include reduce leaflet motion ) endocarditis , etc , - Hemodynamic performance : Maintenance relief stenosis insufficiency without produce opposite ( Stenosis = MVA &lt; 1.5cm2 MV gradient &gt; 5mmHg , Insufficiency = MR &gt; 1+ ) , - Absence para-device complication ( e.g. , PVL &gt; mild , need PPM , erosion , Annular rupture AV Groove disruption , LVOT gradient increase &gt; 10mmHg )</detailed_description>
	<mesh_term>Calcinosis</mesh_term>
	<criteria>Subject severe native mitral annular calcification associate mitral stenosis and/or regurgitation . Qualifying echo must within 60 day date procedure . Subject clinical indication mitral valve replacement , demonstrate report New York Heart Association ( NYHA ) Functional Class II great . The subject least 22 year old . The Heart Team agree subject highrisk inoperable surgical mitral valve repair replacement ( MVR ) , base conclusion probability death serious , irreversible morbidity exceed probability meaningful improvement . The following concomitant procedure , allow MAZE , TVP , atrial fibrillation ( AF ) ablation . The study subject inform nature study , agree provision provide write informed consent approve Institutional Review Board ( IRB ) respective clinical site . The study subject agree comply required postprocedure followup visit Evidence acute myocardial infarction ( MI ) ≤ 30 day intend treatment [ define : Q wave MI , nonQ wave MI total CK elevation CKMB ≥ twice normal presence MB elevation and/or troponin level elevation ( WHO definition ) ] . Untreated coronary artery disease need revascularization Any therapeutic invasive cardiac procedure result permanent implant perform within 30 day index procedure ( unless part plan strategy treatment concomitant coronary artery disease ) . Leukopenia ( white blood cell count &lt; 2000 cell/mL ) , acute anemia ( hemoglobin &lt; 8 g/dL ) , thrombocytopenia ( platelet count &lt; 50,000 cell/mL ) . Hemodynamic respiratory instability require vasoactive medication , mechanical ventilation time procedure . Need emergency surgery reason . Severe leave ventricular dysfunction Left Ventricular Ejection Fraction ( LVEF ) &lt; 30 % . Severe right ventricular dysfunction Pregnancy , lactation , plan become pregnant Echocardiographic evidence leave ventricular mass , thrombus , concern active infective endocarditis . Active upper gastrointestinal ( GI ) bleed within 3 month prior procedure without treatment 30 day prior procedure definitive treatment . A known contraindication hypersensitivity anticoagulation regimen , inability maintain oral anticoagulant follow study procedure . An estimated Glomerular Filtration Rate ( eGFR ) &lt; 30 calculated use Modification Diet Renal Disease ( MDRD ) formula End stage renal disease require dialysis Clinically ( neurologist ) neuroimaging confirm stroke transient ischemic attack ( TIA ) within 30 day procedure . Estimated life expectancy &lt; 12 month</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>mitral valve regurgitation</keyword>
	<keyword>mitral valve stenosis</keyword>
</DOC>